On Tuesday, October 15, researchers from MAPS Public Benefit Corporation (MAPS PBC) conducted the official site initiation visit for our new study site location in Santa Fe, New Mexico, for our ongoing Phase 1 study of the psychological effects of MDMA when used in a therapeutic setting by healthy volunteers. Enrollment in this multi-site study is limited by invitation only to therapists in training to work on MAPS-sponsored clinical trials of MDMA-assisted psychotherapy for PTSD. Our Santa Fe, New Mexico, study is led by Principal Investigator George Greer, M.D. Our Boulder, Colorado, study site is led by Principal Investigator Marcela Ot’alora, M.A., L.P.C. Zhenya Gelfand, M.D., is serving as Principal Investigator at the site in Charleston, South Carolina. As of October 8, 2019, 85 total participants are enrolled in this study. • Learn More
